Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Current Status of Analytical Techniques for Characterization of Protein Stability
Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning
Enabling Total Biopharma Solutions
Pall Life Sciences
Novel Synthetic Adsorptive Depth Filter Media for CHO Harvest Clarification
John Amara, Ph.D. and Michael Dullen Merck, 80 Ashby Road, Bedford, MA, 01730, USA
Continuous processing optimization with smarter tools
Barbara Paldus, Ph.D.
Vice President & General Manager Finesse, part of Thermo Fisher Scientific
Headline News
FDA grants Priority Review to BRUKINSA combination in first-line mantle cell lymphoma
Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss
CAPLYTA shows rapid improvement in bipolar mania in second pivotal Phase III study
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
An Interview with Dr Günter Jagschies, of GE BioProcess teams on What are the main opportunities and challenges in the rapidly evolving Asian biopharma markets?
Presented by An Interview with Dr. Günter Jagschies, business advisor for the GE BioProcess teams
18th June 2018
Extractables and leachables testing using a Quality Risk Management approach
Presented by Dhaval Tapiawala, Principal Scientist at Pfizer and Satish Kumar Mohanvelu, Life Sciences Management Professional at MilliporeSigma
17th October 2018
Just in Time Release of CAR T Cell Therapies During Covid-19
Presented by Irving Ford, Site QA Head multi-product CAR T facility at Bristol Myers Squibb and Lori Daane, Pharma Microbiology Scientific Director at bioMérieux
29th November 2021
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Rationale Design of Valves for Flexible Processing
Best Practices for Achieving Virus Safety
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
